Loading...

GUFICBIO Gufic BioSciences Ltd Other Situations Announcement

Gfc

GFCB

Gufic BioSciences Ltd

(GUFICBIO)

2025 Announcement

Show Summary

Show Summary

Earnings Call Transcript

Earnings Call Recording

Financial Results Publication

Investor Presentation

Acquisition Update

Subsidiary Investments

Management Changes

Annual Compliance Report

Earnings Call Notice

Cost Auditor Resignation

RTA Contact Update

Tax Appeal Filed

Compliance Certificate

Tax Demand Notice

Earnings Call Transcript

Investor Meeting

Earnings Call Recording

Financial Results Published

Investor Presentation

Earnings Call Scheduled

Investor Meeting

Management Appointments

Management Appointment

Equity Share Acquisition

Postal Ballot Notice

Regulation Compliance

RTA Name Change

Earnings Call Transcript

Director Change

Regulatory Fine Imposed

Earnings Call Update

Financial Results

Investor Presentation

Director Appointment

Investor Meeting

Earnings Call Announcement

Compliance Certificate

Directorate Change

Annual General Meeting

Annual General Meeting

Regulatory Fine Dispute

Earnings Call Transcript

Financial Results Update

Earnings Call Recording

Investor Presentation

Directorate Changes

Director Resignation

Earnings Conference Call

Analyst Meeting

Credit Rating Upgrade

Certificate Submission

Equity Shares Transfer to I...

Director Change

Grant of Options

Directorate Change

Director Resignation

Meeting Intimation

Volume Increase Clarification

Earnings Call Transcript

Retirement Announcement

Financial Results Advertise...

Investor Presentation

Earnings Conference Call

Secretarial Compliance

Certificate Submission

Compliance Certificate Subm...

Certificate Submission

Incorporation of Subsidiary

Meeting Intimation

Investor Meeting

Earnings Transcript Disclosure

Earnings Conference Call

Financial Results

Confirmation of Proceeds Ut...

Earnings Conference Call

Certificate Submission

Earnings Conference Call

Incorporation of Subsidiary...

Conference Call Recording U...

Investor Presentation

Clarification on Volume Inc...

Earnings Conference Call

Financial Results

Certificate under Reg. 74 (5)

Allotment approved

Incorporation of Wholly Own...

Approval for Parecoxib 40mg...

Meeting Schedule

Advertisement Publication

Analyst/Investor Meeting

AGM Announcement

Preferential Issue

Earnings Guidance

Financial Statements

Financial Statements

Equity Investments

Divestment of Assets

Earnings Transcript Uploaded

Analyst/Investor Meet Intim...

Financial Statements

Equity Investments

Geographic Expansion

Financial Statements

Management Changes

Debt Restructuring

External Links:

Data:

Gufic Biosciences Ltd. has received a patent in Europe for a stable freeze-dried formulation of Omadacycline Tosylate, effective from June 5, 2023, valid for 20 years.

AI Assistant

Gufic BioSciences Ltd

2025

Announcement

Find Answers

Ask about any part of the document to get insights, explanations, or key details.